National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
NCT Number: NCT01282008
BACKGROUND:
This document outlines the study design and procedures to be used to evaluate a series of corrective statements to augment consumer knowledge and beliefs about smoking as related to past actions of tobacco companies. The statements were ordered by a U.S. Federal Court in U.S. v. Philip Morris USA, Inc., and are intended to target potential misperceptions resultant of past marketing and promotion practices undertaken by the tobacco industry.
OBJECTIVES:
The U.S. Department of Justice has asked NCI to take the lead on developing and testing corrective statements with adult and youth audiences to ensure both message comprehension and avoidance of unintended consequences of message exposure, such as boomerang effects, smoking triggers, or knowledge gaps.
The court has identified five areas that the statements shall address:
1. The adverse health effects of smoking; 2. The addictiveness of smoking and nicotine; 3. The lack of any significant health benefit from smoking low tar, light, ultra light, mild, and natural cigarettes; 4. The tobacco industry s manipulation of cigarette design and composition to ensure optimum nicotine delivery; 5. The adverse health effects of secondhand smoke.
ELIGIBILITY:
Message testing will be undertaken with the following audiences:
* Current smokers (with an oversample of low socioeconomic status individuals) * General population nonsmokers and former smokers (with an oversample of low socioeconomic status individuals) * Spanish-speaking Hispanics * Youth age 14-17
DESIGN:
Both qualitative and quantitative methods (focus groups and post-test comparison group Web-enabled surveys) will be used to develop and test a range of corrective statements in the five areas outlined by the court.
* Focus group participants: 48-64 * Survey participants: 2500
Looking for future studies?
Notify Me14 year–17 year
All sexes
Observational
Bethesda, Maryland, 20892, United States
BACKGROUND:
This document outlines the study design and procedures to be used to evaluate a series of corrective statements to augment consumer knowledge and beliefs about smoking as related to past actions of tobacco companies. The statements were ordered by a U.S. Federal Court in U.S. v. Philip Morris USA, Inc., and are intended to target potential misperceptions resultant of past marketing and promotion practices undertaken by the tobacco industry.
OBJECTIVES:
The U.S. Department of Justice has asked NCI to take the lead on developing and testing corrective statements with adult and youth audiences to ensure both message comprehension and avoidance of unintended consequences of message exposure, such as boomerang effects, smoking triggers, or knowledge gaps.
The court has identified five areas that the statements shall address:
ELIGIBILITY:
Message testing will be undertaken with the following audiences:
DESIGN:
Both qualitative and quantitative methods (focus groups and post-test comparison group Web-enabled surveys) will be used to develop and test a range of corrective statements in the five areas outlined by the court.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Exclusion criteria
Participants will be excluded from focus groups and survey if they work in:
Time frame: Immediately upon exposure to stimuli
Tobacco-related knowledge, attitudes, and beliefs were measured at baseline and after exposure to message stimuli.
National Cancer Institute (NCI)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07710820
Behavior, Smoking
Brandon, Florida, United States
View Trial DetailsNCT07598136
Behavior, Smoking
Maitland, Florida, United States
View Trial DetailsNCT07328594
Addiction, Behavior
Portland, Oregon, United States
View Trial DetailsNCT02576899
Behavior, Health Behavior
Bedford, Massachusetts, United States
View Trial Details